OBI Pharma (4174) — Cash Flow Reinvestment Rate
Latest as of June 2013:
0.12x
OBI Pharma (4174) has a Cash Flow Reinvestment Rate of 0.12x as of June 2013, reinvesting NT$5.80 Million (capex NT$5.80 Million ) from operating cash flow of NT$50.26 Million. Explore OBI Pharma capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.12x
(Capex + Investments) / Operating CF
Total Reinvested
NT$5.80 Million
Capex + Investments
Operating Cash Flow
NT$50.26 Million
TWD
Capital Expenditures
NT$5.80 Million
TWD
Annual Cash Flow Reinvestment Rate for OBI Pharma (None–None)
Year-by-year capital reinvestment analysis for OBI Pharma. For live market cap and broader valuation context, see 4174 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow